Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM, Dowlatshahi DP, Dai J, Becker LM, Hensel J, Snowden LM, Leveille JM, Brunner MR, Holden KW, Hopkins NS, Harris AM, Kumpati J, Whitt MA, Lee JJ, Ostrosky-Zeichner LL, Papanna R, LeBleu VS, Allison JP, Kalluri R.
McAndrews KM, et al. Among authors: kumpati j.
JCI Insight. 2020 Sep 17;5(18):e142386. doi: 10.1172/jci.insight.142386.
JCI Insight. 2020.
PMID: 32796155
Free PMC article.